Form D · Biotechnology
LYPRO BIOSCIENCES INC
Alameda, CA · CIK 0001440507
Offering snapshot reported Sep 7, 2010 · SEC filing
- Reported sold
- $178K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 7, 2010 | Initial | $177,950 | No comparison | 2 | SEC filing |
| Jul 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147359
Source: Form D, filed Sep 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michelle Stecklein Call | Director, Executive |
| Robert O. Ryan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1236 Hawthorne Street
Alameda, CA, 94501-3973
Alameda, CA, 94501-3973